Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).

Salwa Saad M Zghebi; Douglas Steinke; Martin Rutter; Richard Emsley; Darren Ashcroft

doi:10.1111/dme.24_13048

Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).

Salwa Saad M Zghebi, Douglas Steinke, Martin Rutter, Richard Emsley, Darren Ashcroft

Research output: Contribution to conference › Poster › peer-review

Original language	English
Pages	97-98
Number of pages	1
DOIs	https://doi.org/10.1111/dme.24_13048
Publication status	Published - Mar 2016
Event	Diabetes UK Professional Conference UK, Glasgow - Glasgow Duration: 2 Mar 2016 → 4 Mar 2016

Conference

Conference	Diabetes UK Professional Conference UK, Glasgow
City	Glasgow
Period	2/03/16 → 4/03/16

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dme.24_13048

Cite this

Zghebi, S. S. M., Steinke, D., Rutter, M., Emsley, R., & Ashcroft, D. (2016). Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).. 97-98. Poster session presented at Diabetes UK Professional Conference UK, Glasgow, Glasgow. https://doi.org/10.1111/dme.24_13048

@conference{bdd1af1ab8e24eb6a72142e17d9d2407,

title = "Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).",

author = "Zghebi, {Salwa Saad M} and Douglas Steinke and Martin Rutter and Richard Emsley and Darren Ashcroft",

year = "2016",

month = mar,

doi = "10.1111/dme.24_13048",

language = "English",

pages = "97--98",

note = "Diabetes UK Professional Conference UK, Glasgow ; Conference date: 02-03-2016 Through 04-03-2016",

}

Zghebi, SSM , Steinke, D , Rutter, M, Emsley, R & Ashcroft, D 2016, 'Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).', Diabetes UK Professional Conference UK, Glasgow, Glasgow, 2/03/16 - 4/03/16 pp. 97-98. https://doi.org/10.1111/dme.24_13048

Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD). / Zghebi, Salwa Saad M ; Steinke, Douglas ; Rutter, Martin et al.
2016. 97-98 Poster session presented at Diabetes UK Professional Conference UK, Glasgow, Glasgow.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).

AU - Zghebi, Salwa Saad M

AU - Steinke, Douglas

AU - Rutter, Martin

AU - Emsley, Richard

AU - Ashcroft, Darren

PY - 2016/3

Y1 - 2016/3

U2 - 10.1111/dme.24_13048

DO - 10.1111/dme.24_13048

M3 - Poster

SP - 97

EP - 98

T2 - Diabetes UK Professional Conference UK, Glasgow

Y2 - 2 March 2016 through 4 March 2016

ER -

Zghebi SSM , Steinke D , Rutter M, Emsley R, Ashcroft D. Type 2 diabetes therapies and cardiovascular disease: examining the risk of major cardiovascular events during second-line antidiabetic treatments using the Clinical Practice Research Datalink (CPRD).. 2016. Poster session presented at Diabetes UK Professional Conference UK, Glasgow, Glasgow. doi: 10.1111/dme.24_13048